Evidence map›Paper›PMID 36328389›Full record

ArticleBMJ open2022

Perceived feasibility, facilitators and barriers to incorporating point-of-care testing for SARS-CoV-2 into emergency medical services by ambulance service staff: a survey-based approach.

Kile Green, Massimo Micocci, Timothy Hicks, Amanda Winter, Joanne E Martin, Bethany Shinkins, Lisa Shaw, Christopher Price, Kerrie Davies, Joy A Allen

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Point-of-care tests in the emergency medical services: a scoping review.Scandinavian journal of trauma, resuscitation and emergency medicine · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Kile GreenNIHR Newcastle In Vitro Diagnostics Co-operative, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK Kile.Green@newcastle.ac.uk.ORCID 0000-0002-4777-5458
Massimo MicocciNIHR London In Vitro Diagnostics Co-operative, Imperial College London, London, UK.
Timothy HicksNIHR Newcastle In Vitro Diagnostics Co-operative, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.ORCID 0000-0002-0942-696X
Amanda WinterNIHR Newcastle In Vitro Diagnostics Co-operative, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
Joanne E MartinCentre for Genomics and Child Health, Barts and The London NHS Trust, Blizard Institute, London, UK.
Bethany ShinkinsAcademic Unit of Health Economics, University of Leeds, Leeds, UK.
Lisa ShawStroke Research Group, Population Health Sciences, Newcastle University, Newcastle upon Tyne, UK.
Christopher PriceInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Kerrie DaviesHealthcare Associated Infections Research Group, University of Leeds, Leeds, UK.
Joy A AllenNIHR Newcastle In Vitro Diagnostics Co-operative, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
NIHR Leeds In Vitro Diagnostics Co-operative · GBNewcastle University · GBUniversity of Leeds · GBBarts Health NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis body of work aimed to elicit ambulance service staff's perceptions on the barriers and facilitators to adoption, and clinical utility of incorporating rapid SARS-CoV-2 testing during ambulance assessments.

designA mixed-methods survey-based project using a framework analysis method to organise qualitative data.

settingEmergency and non-emergency care ambulatory services in the UK were approached to take part.

participantsCurrent, practising members of the UK ambulance service (paramedics, technicians, assistants and other staff) were included in this body of work.

resultsSurvey 1: 226 responses were collected between 3 December 2020 and 11 January 2021, 179 (79.2%) of which were completed in full. While the majority of respondents indicated that an ambulance-based testing strategy was feasible in concept (143/190, 75.3%), major barriers to adoption were noted. Many open-ended responses cited concerns regarding misuse of the service by the general public and other healthcare services, timing and conveyance issues, and increased workloads, alongside training and safety concerns. Survey 2: 26 responses were received between 8 February 2021 and 22 February 2021 to this follow-up survey. Survey 2 revealed conveyance decision-making, and risk stratification to be the most frequently prioritised use cases among ambulance service staff. Optimal test characteristics for clinical adoption according to respondents were; accuracy (above 90% sensitivity and specificity), rapidity (<30 min time to results) and ease of sample acquisition.

conclusionsThe majority of commercially available lateral flow devices are unlikely to be supported by paramedics as their duty of care requires both rapid and accurate results that can inform clinical decision making in an emergency situation. Further investigation is needed to define acceptable test characteristics and criteria required for ambulance service staff to be confident and supportive of deployment of a SARS-CoV-2 test in an emergency care setting.

Indexed as

COVID-19Emergency Medical ServicesAmbulancesCOVID-19 TestingFeasibility StudiesHumansPoint-of-Care TestingSARS-CoV-2Surveys and QuestionnairesCOVID-19Molecular diagnosticsQUALITATIVE RESEARCH

Identifiers

PMID36328389
PMCPMC9638752
OpenAlexW4308430050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.